NM_000204.5:c.58-4251C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000204.5(CFI):​c.58-4251C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.241 in 151,878 control chromosomes in the GnomAD database, including 5,035 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 5035 hom., cov: 30)

Consequence

CFI
NM_000204.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.358

Publications

2 publications found
Variant links:
Genes affected
CFI (HGNC:5394): (complement factor I) This gene encodes a serine proteinase that is essential for regulating the complement cascade. The encoded preproprotein is cleaved to produce both heavy and light chains, which are linked by disulfide bonds to form a heterodimeric glycoprotein. This heterodimer can cleave and inactivate the complement components C4b and C3b, and it prevents the assembly of the C3 and C5 convertase enzymes. Defects in this gene cause complement factor I deficiency, an autosomal recessive disease associated with a susceptibility to pyogenic infections. Mutations in this gene have been associated with a predisposition to atypical hemolytic uremic syndrome, a disease characterized by acute renal failure, microangiopathic hemolytic anemia and thrombocytopenia. Primary glomerulonephritis with immune deposits and age-related macular degeneration are other conditions associated with mutations of this gene. [provided by RefSeq, Dec 2015]
CFI Gene-Disease associations (from GenCC):
  • atypical hemolytic-uremic syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • atypical hemolytic-uremic syndrome with I factor anomaly
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complement factor I deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • Doyne honeycomb retinal dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • age related macular degeneration 13
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.347 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CFINM_000204.5 linkc.58-4251C>T intron_variant Intron 1 of 12 ENST00000394634.7 NP_000195.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CFIENST00000394634.7 linkc.58-4251C>T intron_variant Intron 1 of 12 1 NM_000204.5 ENSP00000378130.2
ENSG00000285330ENST00000645635.1 linkc.58-4251C>T intron_variant Intron 1 of 14 ENSP00000493607.1

Frequencies

GnomAD3 genomes
AF:
0.241
AC:
36578
AN:
151760
Hom.:
5032
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.114
Gnomad AMI
AF:
0.357
Gnomad AMR
AF:
0.354
Gnomad ASJ
AF:
0.289
Gnomad EAS
AF:
0.255
Gnomad SAS
AF:
0.236
Gnomad FIN
AF:
0.313
Gnomad MID
AF:
0.351
Gnomad NFE
AF:
0.276
Gnomad OTH
AF:
0.274
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.241
AC:
36584
AN:
151878
Hom.:
5035
Cov.:
30
AF XY:
0.244
AC XY:
18101
AN XY:
74188
show subpopulations
African (AFR)
AF:
0.114
AC:
4714
AN:
41466
American (AMR)
AF:
0.355
AC:
5410
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.289
AC:
1002
AN:
3466
East Asian (EAS)
AF:
0.255
AC:
1315
AN:
5152
South Asian (SAS)
AF:
0.236
AC:
1134
AN:
4804
European-Finnish (FIN)
AF:
0.313
AC:
3298
AN:
10540
Middle Eastern (MID)
AF:
0.344
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
0.276
AC:
18708
AN:
67890
Other (OTH)
AF:
0.274
AC:
577
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1324
2647
3971
5294
6618
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
378
756
1134
1512
1890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.267
Hom.:
796
Bravo
AF:
0.242
Asia WGS
AF:
0.268
AC:
933
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
13
DANN
Benign
0.79
PhyloP100
0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12512308; hg19: chr4-110692231; API